Transform complex glaucoma surgery into an elegant, minimally-invasive laser-assisted procedure.

IOPtima Ltd. develops, produces and distributes novel surgical treatments for glaucoma. Our flagship product, the IOPtiMate™, is an innovative surgical system performing CO₂ Laser Assisted Filtration Surgery. As an alternative to conventional surgery, the system is designed to provide long-term relief from excessive intraocular pressure and reduce reliance on anti-Glaucoma drugs.

The IOPtiMate™ CO₂ Laser Assisted Filtration Surgery system harnesses the CO₂ laser properties, as it gradually ablates the sclera tissue, exposing Schlemm’s canal and trabecular meshwork until the remaining layer is thin enough and intra ocular aqueous percolates through the intact layer. The percolation fluid effectively absorbs the CO₂ laser energy, essentially prevents over-ablation and minimizing the risk of penetrating the eye.

As the IOPtiMate™ CO₂ Laser Assisted Filtration Surgery is a non-penetrating filtration procedure, it significantly reduces the known risks of intra- and post-operative complications as well as the follow-up interventions commonly associated with penetrating surgical alternatives.

The system is CE approved, commercially available and used in major European medical centers.